The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby…
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Duloxetine Delayed-Release Capsules USP
- Published
- 5 Feb 2025
- Units affected
- a) 6408 boxes and b)1488 boxes
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.
- Brand / company
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
- Codes / lots
- Lot #: a) N01530, Exp. Date 01/2025; b) N01540, Exp. Date. 01/2025
- Distribution
- Nationwide within the United States
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 5 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.